Il mercato degli aghi cardiovascolari è stato valutato a 84,429 milioni di dollari nel 2021 e si prevede che raggiungerà 137,855 milioni di dollari entro il 2028; si prevede che crescerà a un CAGR del 7,3% dal 2021 al 2028.
Gli aghi cardiovascolari vengono utilizzati durante interventi chirurgici a cuore aperto, procedure valvolari cardiache, procedure di trapianto, interventi chirurgici di innesto di bypass coronarico e così via. Questi aghi sono di due tipi: aghi monouso o senza cruna e aghi multiuso o con cruna. Gli aghi cardiovascolari sono realizzati con nuove leghe di acciaio inossidabile che costituiscono alte concentrazioni di nichel, Surgalloy ed Ethalloy.
;
Il mercato degli aghi cardiovascolari è stato segmentato in base al tipo, all'applicazione, all'utilizzo, all'utente finale e alla geografia. Il mercato, per geografia, è segmentato principalmente in Nord America, Europa, Asia Pacifico, Medio Oriente e Asia. Africa e Sud & America Centrale. Il rapporto offre approfondimenti e analisi approfondite del mercato degli aghi cardiovascolari, sottolineando parametri quali tendenze di mercato, progressi tecnologici e dinamiche di mercato insieme all’analisi del panorama competitivo dei principali attori del mercato a livello globale.
Approfondimenti strategici
Regioni redditizie per il mercato degli aghi cardiovascolariApprofondimenti di mercato
In aumento La prevalenza delle malattie cardiovascolari stimola la crescita del mercato degli aghi cardiovascolari
Le malattie cardiovascolari (CVD) sono disturbi del cuore e dei vasi sanguigni e la categoria comprende malattie cerebrovascolari, malattie coronariche, malattie cardiache reumatiche e altre condizioni. Il consumo di tabacco, una dieta non sana e l’inattività fisica, che aumentano il rischio di infarti e ictus, sono alcuni dei principali fattori legati allo stile di vita che portano alle malattie cardiovascolari. Altri fattori di rischio che causano queste malattie includono ipertensione, diabete e aumento dei livelli di colesterolo. Le malattie cardiovascolari sono tra le prime 10 cause di morte nel mondo. Secondo l’Organizzazione Mondiale della Sanità (OMS), le malattie cardiovascolari sono la prima causa di morte nel mondo. È probabile che le malattie cardiovascolari (CVD) rimangano la principale causa di morbilità e mortalità in tutto il mondo. Secondo i dati dell’OMS, nel 2016 sono morte a causa di malattie cardiovascolari circa 17,9 milioni di persone nel mondo, ovvero il 31,0% della mortalità totale segnalata in quell’anno. Tra questi, circa l’85% dei casi di morte sono dovuti ad infarto e ictus. I depositi di grasso attorno ai vasi sanguigni che impediscono al sangue di fluire al cuore o al cervello sono una delle principali cause di infarto e ictus. Vasi sanguinanti o coaguli di sangue nel cervello sono alcune altre cause di ictus.
Secondo le statistiche europee sulle malattie cardiovascolari del 2017, le malattie cardiovascolari causano 3,9 milioni e oltre 1,8 milioni di casi di morte in Europa e Unione Europea (UE), rispettivamente, ogni anno. Pertanto, queste malattie rappresentano rispettivamente il 45,0% e il 37,0% della mortalità totale in Europa e nell’UE. Inoltre, secondo le statistiche del 2019 dell’American Heart Association (AHA), 121,5 milioni di adulti negli Stati Uniti, ovvero circa il 50% della popolazione adulta statunitense, soffrono di malattie cardiovascolari ogni anno. Secondo il Journal of American College of Cardiology, l’Asia ha una prevalenza sempre più elevata di ipertensione, diabete e livelli elevati di colesterolo. Paesi come il Giappone, la Cina e l’India contribuiscono maggiormente all’incidenza totale delle malattie cardiovascolari nella regione. Pertanto, l’incidenza significativamente crescente di malattie cardiovascolari in tutto il mondo sta contribuendo all’elevata domanda di dispositivi cardiovascolari diagnostici e terapeutici, che sta guidando la crescita del mercato degli aghi cardiovascolari.
Approfondimenti basati sul tipo
In base al tipo, il mercato degli aghi cardiovascolari è segmentato in aghi a corpo rotondo e aghi taglienti. Il segmento degli aghi a corpo tondo rappresenterebbe una quota di mercato maggiore nel 2021 e si prevede che il segmento degli aghi da taglio registrerà un CAGR più elevato nel mercato durante il periodo di previsione.
Mercato degli aghi cardiovascolari, per tipo: – 2021 E 2028Approfondimenti basati sull'applicazione
In base all'applicazione, il mercato degli aghi cardiovascolari è segmentato in cardiochirurgia e procedure valvolari cardiache. Si prevede che il segmento della chirurgia a cuore aperto deterrà una quota maggiore del mercato nel 2021 e si stima che registrerà un CAGR più elevato nel mercato durante il periodo 2021-2028. La crescita del segmento della chirurgia a cuore aperto è attribuita all'aumento degli interventi a cuore aperto in tutto il mondo.
Approfondimenti basati sull'utilizzo
Basati su utilizzo, il mercato degli aghi cardiovascolari è segmentato in uso singolo e uso multiplo. Si stima che il segmento monouso rappresenterà una quota di mercato maggiore nel 2021. Si stima che il mercato per questo segmento crescerà a un CAGR più elevato dal 2021 al 2028.
Approfondimenti basati sull'utente finale
In base all'utente finale, il mercato degli aghi cardiovascolari è segmentato in ospedali e cliniche, centri chirurgici ambulatoriali e centri cardiovascolari. Il segmento degli ospedali e delle cliniche deterrà la quota maggiore del mercato nel 2021; si stima inoltre che registrerà il CAGR più elevato del mercato durante il periodo di previsione.
La pandemia di COVID-19 è diventata la sfida più significativa attraverso il mondo. Poiché questa pandemia ha messo a dura prova i sistemi sanitari di tutto il mondo, dare priorità alle risorse limitate era essenziale per ridurre al minimo i ricoveri ospedalieri. I pazienti cardiochirurgici non solo necessitano di risorse vitali in terapia intensiva, ma sono anche potenzialmente nella categoria a più alto rischio di complicanze di COVID-19. Pertanto, la maggior parte degli ospedali e degli operatori chirurgici ha considerato di annullare o rinviare gli interventi chirurgici elettivi, compresi gli interventi cardiovascolari. Pertanto si prevede che l’impatto di COVID 19 sarà alquanto negativo sul mercato degli aghi cardiovascolari nel breve termine. Tuttavia, a lungo termine, man mano che il programma di vaccinazione verrà stabilito e il tasso di trasmissione diminuirà, i sistemi sanitari torneranno alla normalità e avranno una maggiore domanda di aghi cardiovascolari, che sosterrà il mercato.
Acquisizioni, collaborazioni, partnership, lanci di prodotti ed espansioni sono strategie comunemente adottate dalle aziende per espandere la propria presenza in tutto il mondo e soddisfare la crescente domanda. Gli attori del mercato degli aghi cardiovascolari hanno adottato principalmente la strategia dell'innovazione di prodotto per soddisfare la mutevole domanda dei clienti in tutto il mondo, il che li aiuta anche a mantenere il loro marchio a livello globale.
Profili aziendali
- Ethicon (Johnson & Johnson Services, Inc.)
- Mani, Inc
- Barbiere di Sheffield ;
- Aghi chirurgici FSSB GmbH
- Medtronic
- Aurolab
- Teleflex Incorporated
- Meril Life Sciences Pvt. Ltd.
- CP Medical
- SMB Corporation of India
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Cardiovascular Needle market majorly consists of the players such as players Ethicon (Johnson & Johnson Services, Inc.), MANI, INC., Barber of Sheffield, FSSB surgical needles GmbH, Medtronic, Aurolab., Teleflex Incorporated., Meril Life Sciences Pvt. Ltd., CP Medical., SMB Corporation of India and among others.
The factors that are restraining the adoption of cardiovascular needle are increasing use of surgical staples instead of needles and suture.
The factors that are driving growth of the market are increase in prevalence of cardiovascular diseases across the world and rising geriatric population. There are also other factors that fuel the growth of the market such as excessive intake of tobacco, high number of smoking population, obesity, increasing co-morbidities, and changing standard of living.
The cardiovascular needles are used during a number of cardiovascular surgeries such as open-heart surgery, cardiac valve procedures, heart transplant, coronary artery bypass graft surgery, and many more surgeries need surgical needles. These cardiovascular needles are of two types: single use or eyeless needles and multiple use or eyed needles. Cardiovascular needles are manufactured from new stainless-steel alloys containing high concentrations of nickel, Surgalloy and Ethalloy.
The List of Companies - Cardiovascular Needle Market
- Ethicon (Johnson & Johnson Services, Inc.)
- MANI, INC
- Barber of Sheffield
- FSSB surgical needles GmbH
- Medtronic
- Aurolab
- Teleflex Incorporated
- Meril Life Sciences Pvt. Ltd.
- CP Medical
- SMB Corporation of India
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Sep 2021
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Sep 2021
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Sep 2021
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)